[go: up one dir, main page]

FI72146C - Procedure for Identifying Nucleic Acids. - Google Patents

Procedure for Identifying Nucleic Acids. Download PDF

Info

Publication number
FI72146C
FI72146C FI850004A FI850004A FI72146C FI 72146 C FI72146 C FI 72146C FI 850004 A FI850004 A FI 850004A FI 850004 A FI850004 A FI 850004A FI 72146 C FI72146 C FI 72146C
Authority
FI
Finland
Prior art keywords
hybridization
poly
probe
affinity pair
dna
Prior art date
Application number
FI850004A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI850004A0 (en
FI72146B (en
FI850004L (en
Inventor
Hans Erik Soederlund
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of FI850004A0 publication Critical patent/FI850004A0/en
Priority to FI850004A priority Critical patent/FI72146C/en
Priority to CH5378/85A priority patent/CH666696A5/en
Priority to GB08531414A priority patent/GB2169403B/en
Priority to BE0/216059A priority patent/BE903937A/en
Priority to JP60299797A priority patent/JPH0669400B2/en
Priority to NO855308A priority patent/NO166743C/en
Priority to HU855030A priority patent/HU196453B/en
Priority to DE19853546312 priority patent/DE3546312A1/en
Priority to LU86238A priority patent/LU86238A1/en
Priority to IT23408/85A priority patent/IT1201514B/en
Priority to RO121637A priority patent/RO94651B/en
Priority to AT0376785A priority patent/AT397514B/en
Priority to ZA859895A priority patent/ZA859895B/en
Priority to FR858519394A priority patent/FR2575493B1/en
Priority to AU51748/85A priority patent/AU561382B2/en
Priority to IE333385A priority patent/IE58290B1/en
Priority to CA000498834A priority patent/CA1271705A/en
Priority to NLAANVRAGE8503597,A priority patent/NL189427C/en
Priority to IL77489A priority patent/IL77489A/en
Priority to SE8600011A priority patent/SE463212B/en
Priority to DK000386A priority patent/DK164932C/en
Publication of FI850004L publication Critical patent/FI850004L/en
Publication of FI72146B publication Critical patent/FI72146B/en
Application granted granted Critical
Publication of FI72146C publication Critical patent/FI72146C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)

Description

721 46721 46

Menetelmä nukleiinihappojen tunnistamiseksiMethod for identification of nucleic acids

Keksinnön kohteena on menetelmä nukleiinihappojen tunnistamiseksi liuoksessa tapahtuvan hybridisaaticn avulla.The invention relates to a method for the identification of nucleic acids by hybridization in solution.

05 Keksinnön mukaiselle menetelmälle on tunnusomaista, että hybridisaatioreaktiossa käytetään kahta samassa liuoksessa olevaa koetinta. Detektorikoetin on leimattu merkkiaineella ja nk. kiinnitinkoettimeen on kiinnitetty komponentti, joka voi toimia osapuolena affiniteetiparissa, jolloin hybridi-10 säätiössä muodostunut kiinnitinkoetin:näyte:detektorikoetin--hybridi voidaan erottaa muista hybridisaatioseoksessa olevista komponenteista affiniteettiparin toisen osapuolen avulla.The method according to the invention is characterized in that two probes in the same solution are used in the hybridization reaction. The detector probe is labeled with a marker and a so-called clamp the probe is attached to a component that can act as a party affiniteetiparissa, the hybrid-formed foundation fastener 10 probe: the sample. Detector probe - the hybrid may be separated from other components of the hybridization mixture for the second party by means of an affinity pair.

15 Nukleiinihappojen tunnistamisessa on käytetty erilaisia hybridisaatiomenetelmiä. Esimerkkeinä voidaan mainita suorat hybridisaatiomenetelmät ja kerroshybridisaatiomenetelmät. Suorissa hybridisaatiomenetelmissä nukleiinihapponäyte on joko liuoksessa tai kiinnitettynä kiinteään kantajaan.Various hybridization methods have been used to identify nucleic acids. Examples include direct hybridization methods and layer hybridization methods. In direct hybridization methods, the nucleic acid sample is either in solution or attached to a solid support.

20 Tunnistettava nukleiinihappo osoitetaan käyttäen yhtä leimattua koetinta. Kerroshybridisaatiomenetelmissä (ΓΙ 63596) käytetään kahta erillistä koetinta, joilla osoitetaan tunnistettava nukleiinihappo näyteliuoksesta. Toinen käytetyistä koettimista on leimattu merkkiaineella ja toinen on 25 kiinnitetty kiinteään kantajaan.The nucleic acid to be identified is detected using a single labeled probe. Layer hybridization methods (ΓΙ 63596) use two separate probes to detect the identifiable nucleic acid from the sample solution. One of the probes used is labeled with a marker and the other is attached to a solid support.

Olemme kehittäneet uuden hybridisaatiomenetelmän, jossa käytetään kahta erilaista koetinta mutta molemmat koettimet ovat samassa liuosfaasissa. Koska hybridisaatioon osallistuva 30 näyte ja molemmat koettimet ovat samassa liuosfaasissa, hybridisaatioreaktio tapahtuu huomattavasti nopeammin kuin kerroshybridisaatiossa, jossa toinen koetin on kiinnitetty kiinteään kantajaan. Keksinnön mukaisessa menetelmässä tunnin inkubointiaika on riittävä. Yksivaiheisessa kerroshybridi-35 säätiössä (FI 63596) riittävä hybridisaatio tapahtuu vasta 12 2 721 46 tunnissa. Kun suoritetaan kaksivaiheista kerroshybridisaati-ota, tarvitaan vähintään 24 tunnin hybridisaatioaika (Dunn ja Hassell, Cell 12, 23-36, 1977).We have developed a new hybridization method using two different probes but both probes are in the same solution phase. Because the sample involved in the hybridization and both probes are in the same solution phase, the hybridization reaction proceeds significantly faster than in layer hybridization, where one probe is attached to a solid support. In the method according to the invention, an incubation time of one hour is sufficient. In a single-stage layered hybrid-35 foundation (FI 63596), sufficient hybridization occurs only in 12 2 721 46 hours. When performing a two-step layer hybridization, a hybridization time of at least 24 hours is required (Dunn and Hassell, Cell 12, 23-36, 1977).

05 Keksinnön mukaisessa menetelmässä käytetään edullisesti kahta koetinta. Koettimet ovat tunnistettavaksi tarkoitetulle nukleiinihapolle riittävän homologisia nukleiinihappofrag-mentteja. On edullista, mutta ei välttämätöntä, jos koettimet ovat homologisia suhteellisen lähellä toisiaan sijaitseville 10 kohdille tunnistettavassa nukleiinihapossa. Koettimet eivät saa olla toisilleen homologisia.In the method according to the invention, two probes are preferably used. The probes are nucleic acid fragments sufficiently homologous to the nucleic acid to be identified. It is preferred, but not essential, that the probes be homologous to relatively close to 10 sites in the nucleic acid to be identified. The probes must not be homologous to each other.

Koettimet voidaan valmistaa synteettisesti, puolisynteetti-sesti, yhdistelmä-DNA-tekniikalla tai suoraan luonnosta 15 eristetyistä nukleiinihapoista. Koetin voi olla sopivaan vektoriin sidottu. Se voi sisältää vektoriosia tai olla täysin vapaa vektoriosista.Probes can be prepared synthetically, semi-synthetically, by recombinant DNA technology, or directly from nucleic acids isolated from nature. The probe may be bound to a suitable vector. It may contain vector elements or be completely free of vector elements.

Detektorikoetin on leimattu sopivilla merkkiaineilla.The detector probe is labeled with suitable markers.

20 Merkkiaineina voidaan käyttää erilaisia radioaktiivisia isotooppeja tai radioaktiivisesti leimattuja yhdisteitä. Merkkiaine voi myös olla fluoresoiva, luminesoiva, valoa emittoiva, entsymaattisesti tai immunologisesti osoitettavissa oleva jne. Esimerkkeinä voidaan mainita biotiinin ja 25 avidiinin tai streptavidiinin affiniteettiin perustuvat merkkiaineet (Leary et ai., P.N.A.S. 80, 4045-4049, 1983), lantanidikelaatit (US 4,243,880 ja US 4,374,120), ferritiini-ja hemeyhdisteet, immunologisesti osoitettavat hapteenit kuten AAF ja AIF (erilaiset asetoksiasetyylifluoreenideri-30 vaatit (WO 8302286)). Myös proteiinien välityksellä tapahtuva tunnistaminen on mahdollista. Keksinnön mukainen menetelmä ei ole riippuvainen käytetystä merkkiaineesta. Menetelmään voidaan vapaasti soveltaa kaikki tunnetut nukleiinihappo-hybridisaatioon soveltuvat merkkiaineet.Various radioactive isotopes or radiolabeled compounds can be used as tracers. The label may also be fluorescent, luminescent, light emitting, enzymatically or immunologically detectable, etc. Examples include labels based on the affinity of biotin and avidin or streptavidin (Leary et al., PNAS 80, 4045-4049, 1983), lanthanide chelates (US lanthanide chelates). and U.S. 4,374,120), ferritin and hemic compounds, immunologically detectable haptens such as AAF and AIF (various acetoxyacetylfluorene derivative requirements (WO 8302286)). Protein-mediated identification is also possible. The method according to the invention is not dependent on the tracer used. All known markers suitable for nucleic acid hybridization are freely applicable to the method.

Il 72146 3Il 72146 3

Kiinnitinkoettimeen on kiinnitetty komponentti, joka voi toimia osapuolena affiniteettiparissa. Tällaisia affiniteet-tipareja ovat esimerkiksi biotiini-avidiini tai biotiini-streptavidiini, raskasmetalliderivaatti-tioryhmä (Dale and 05 Ward, Biochemistry 14, No 11, 2458-2469, 1975), erilaiset homopolynukleotidit, esimerkiksi poly dG - poly dc, poly dA - poly dT tai poly dA - poly U. Mutta myös muita affiniteettipareja voidaan käyttää, kunhan komponenteilla on tarpeeksi voimakas affiniteetti toisiinsa. Immunologisissa 10 menetelmissä käytettyjen ligandien ja konjugaattien joukosta löytyy sopivia affiniteettipareja.Attached to the fastener probe is a component that can act as a party in the affinity pair. Such affinity droplets are, for example, biotin-avidin or biotin-streptavidin, a heavy metal derivative thio group (Dale and 05 Ward, Biochemistry 14, No. 11, 2458-2469, 1975), various homopolynucleotides, for example poly dG - poly dc, poly dA - poly dT or poly dA - poly U. But other affinity pairs can also be used as long as the components have a sufficiently strong affinity for each other. Among the ligands and conjugates used in immunological methods, suitable affinity pairs can be found.

Ennen hybridisaatioreaktion suorittamista näyte käsitellään siten, että nukleiinihapot vapautuvat hybridisaatioliuokseen 15 yksisäikeisessä muodossa. Hybridisaatio suoritetaan hybridi-saatioseoksessa, jossa nukleiinihapot, detektorikoetin ja kiinnitinkoetin on tarvittaessa saatettu yksisäikeiseen muotoon. Hybridisaatioliuoksena voidaan käyttää erilaisia tarkoitukseen sopivia puskureita. Hybridisaatio tapahtuu 20 lämpötilavälillä 0-80°C, mutta edullista on käyttää 65°C:n lämpötilaa. Jos hybridisaatioliuos sisältää formamidia (40-55 %), voidaan käyttää 37°C lämpötilaa. Hybridisaatio-ajaksi riittää tunti.Prior to performing the hybridization reaction, the sample is treated so that the nucleic acids are released into the hybridization solution in a single-stranded form. The hybridization is performed in a hybridization mixture in which the nucleic acids, the detector probe and the attachment probe have been brought into a single-stranded form, if necessary. Various suitable buffers can be used as the hybridization solution. Hybridization occurs at a temperature in the range of 0-80 ° C, but it is preferred to use a temperature of 65 ° C. If the hybridization solution contains formamide (40-55%), a temperature of 37 ° C can be used. An hour is enough for the hybridization time.

25 Kun hybridisaatio on tapahtunut, liuosta laimennetaan tarvittaessa siten, että olosuhteet ovat edullisia affini-teettiparille. Tämän jälkeen seos saatetaan kontaktiin affiniteettiparin toisen osapuolen kanssa, joka on kytkettynä sopivaan kantajaan. Kantajana voi toimia esimerkiksi affini-30 teettikromatografiapylväs, filtteri, muovi- tai lasipinta.Once hybridization has taken place, the solution is diluted, if necessary, so that the conditions are favorable for the affinity pair. The mixture is then brought into contact with the other party of an affinity pair which is coupled to a suitable carrier. The support can be, for example, an affinity chromatography column, a filter, a plastic or glass surface.

Affiniteettikantajan materiaali voi olla esimerkiksi selluloosaa, latexia, polyakrylamidia, dextraania tai agaroosia. Näitä materiaaleja voidaan käyttää myös suspensioina 35 koeputkessa. Edullista on myös käyttää koeputkia, joiden 4 72146 sisäpintaan on kiinnitettynä affiniteettiparin toinen osapuoli. Materiaalien valinta edellyttää, että siihen voidaan kiinnittää komponentti, jolla on affiniteettia kiinnitinkoettimeen kiinnitettyyn komponenttiin.The material of the affinity carrier may be, for example, cellulose, latex, polyacrylamide, dextran or agarose. These materials can also be used as suspensions in 35 test tubes. It is also preferred to use test tubes with the other side of the affinity pair attached to the inner surface of the 4 72146. The choice of materials requires that a component with affinity for the component attached to the attachment probe be attached.

0505

Mikäli näyte sisältää tunnistettavaksi tarkoitettua nukleiinihappoa, hybridisaatiossa syntyy kiinnitinkoetin:näyte: detektorikoetin-hybridi. Tämä hybridi tarttuu fraktioinnissa kiinteään kantajaan. Kantajaan tarttuneen fraktion leima 10 voidaan mitata tavanomaisin menetelmin suoraan kantajasta tai eluoinnin jälkeen eluoidusta liuoksesta.If the sample contains nucleic acid for identification, hybridization results in an attachment probe: sample: detector probe hybrid. This hybrid adheres to the solid support during fractionation. The label 10 of the fraction adhering to the support can be measured by conventional methods directly from the support or from the solution eluted after elution.

Fraktioinnissa voidaan affiniteettikromatografiän tilalla käyttää myös muita järjestelmiä, esimerkiksi faasiekstrakti-15 ota tai magneettikenttiä.Other systems, such as phase extract or magnetic fields, can be used in the fractionation instead of affinity chromatography.

Seuraavissa sovellutusesimerkeissä keksinnön mukainen menetelmä kuvataan tarkemmin. Keksinnön mukainen menetelmä ei ole riippuvainen esimerkeissä käytetyistä nukleiinihappo-20 fragmenteista. Alan asiantuntijalle on itsestään selvää miten vastaavanlaisia nukleiinihappofragmentteja voidaan valmistaa.In the following application examples, the method according to the invention is described in more detail. The method of the invention is not dependent on the nucleic acid-20 fragments used in the examples. It will be apparent to one skilled in the art how similar nucleic acid fragments can be prepared.

Esimerkki 1 25 Adenoviruksen DNA:n tunnistaminen solulysaatista käyttäen homopolynukleotidia 125Example 1 Identification of adenovirus DNA from a cell lysate using homopolynucleotide 125

Detektorikoettimena käytettiin lilla leimattua rekombi-nanttifaagia mkTH 1206, joka on adenoviruksen (tyyppi 2) 30 Bgl II fragmentti adenoviruksen geenikartan positiosta 42-45,3 %. Kyseinen rekombinanttifaagi on deponoitu kantakokoelmaan Deutsche Sammlung von Mikroorganismen numerolla DSM 2827 ja sen spesifinen aktiivisuus on 7 7 x 10 cpm/jug DNA. Koetin on kuvattu tarkemmin julkaisussa 35 Ranki et ai., Gene 21., 77-85, 1983.Purple-labeled recombinant phage mkTH 1206, a 30 Bgl II fragment of adenovirus (type 2) from position 42-45.3% of the adenovirus gene map, was used as a detector probe. This recombinant phage has been deposited in the strain collection Deutsche Sammlung von Mikroorganismen under number DSM 2827 and has a specific activity of 7 7 x 10 cpm / μg DNA. The probe is described in more detail in 35 Ranki et al., Gene 21., 77-85, 1983.

5 721465 72146

Kiinnitinkoettimena käytettiin rekombinanttiplasmidia pkTH 1202, joka on deponoitu kantakokoelmaan Deutsche Sammlung von Mikro-organismen numerolla DSM 2824 ja koostuu adenoviruksen BamHI D fragmentista (karttapositio 29-42 %) kloonattuna 05 pBR322 plasmidiin. Rekombinanttiplasmidi pkTH 1202 (DSM 2824) pilkottiin restriktioentsyymillä Hae III ja fragmenttien 3' päihin liitettiin poly A-häntä terminaalitransferaasient-syymin avulla. Hännän pituus mitattiin H-A inkorporaatiolla. Pituus oli keskimäärin n. 70 A-tähdettä. Ennen käyttöä 10 kiinnitin denaturoitiin keittämällä. Näytteenä käytettiin adenovirukselle infektoituja A-549 soluja. Infektoituja soluja inkuboitiin 2i tuntia. Solut kerättiin ja rikottiin 1 %:lla natriumdodekyylisulfaattiliuoksella. Liuos sisälsi n. 106 solua/ml. Viskositeetti alennettiin sonikoimalla.The recombinant plasmid pkTH 1202, deposited in the strain collection Deutsche Sammlung von Microorganism under the number DSM 2824 and consisting of a BamHI D fragment of adenovirus (map position 29-42%) cloned into plasmid pBR322, 05 was used as a ligand probe. The recombinant plasmid pkTH 1202 (DSM 2824) was digested with the restriction enzyme Hae III and the poly A tail was ligated to the 3 'ends of the fragments using a terminal transferase enzyme. The tail length was measured by H-A incorporation. The average length was about 70 A residues. Prior to use, the fastener 10 was denatured by boiling. Adenovirus-infected A-549 cells were used as a sample. Infected cells were incubated for 2 hours. Cells were harvested and disrupted with 1% sodium dodecyl sulfate solution. The solution contained about 106 cells / ml. The viscosity was reduced by sonication.

15 Kontrollina käytettiin ei-infektoituja A-549 soluja, joita käsiteltiin identtisesti. Ennen hybridisaatiota näytettä keitettiin 5 min. 0,02 M NaOH:ssa, jäähdytettiin 0°C:ksi ja neutraloitiin etikkahapolla.Uninfected A-549 cells treated identically were used as controls. Prior to hybridization, the sample was boiled for 5 min. In 0.02 M NaOH, cooled to 0 ° C and neutralized with acetic acid.

20 Testiä varten yhdistettiin koeputkessa 500.000 cpm detektori-koetinta, 50 ng kiinnitin-DNA:ta ja 10 /ui näytettä. Tilavuus säädettiin 50 /uliksi ja puskuriliuoksena käytettiin 0,6 M natriumkloridia 0,06 M natriumsitraattia, 0,02 M natriumfos-faattia (pH 7,6) ja 0,5 % natriumdodekyylisulfaattia. Seosta 25 inkuboitiin 1 tunti 65°C:n lämpötilassa.For the assay, 500,000 cpm of detector probe, 50 ng of fixative DNA, and 10 sample were combined in a test tube. The volume was adjusted to 50 and 0.6 M sodium chloride, 0.06 M sodium citrate, 0.02 M sodium phosphate (pH 7.6) and 0.5% sodium dodecyl sulfate were used as buffer solution. Mixture 25 was incubated for 1 hour at 65 ° C.

Hybridisaation jälkeen liuos jäähdytettiin + 20°C:ksi ja valutettiin hitaasti läpi kromatografiapatsaan, jossa oli 1 ml oligo dT-selluloosaa. Läpimennyt liuos otettiin talteen 30 ja valutettiin uudestaan patsaan läpi. Sen jälkeen patsasta pestiin 20 ml:lla liuosta, joka sisälsi 0,15 M natriumklori-dia, 0,015 M natriumfosfaattia (pH 7,6) ja 0,5 % natriumdodekyylisulfaattia. Kiinnittynyt DNA irroitettiin lopulta 1 ml:lla 0,02 M NaOHilla. Tämä liuos otettiin talteen ja sen 35 radioaktiivisuus määritettiin.After hybridization, the solution was cooled to + 20 ° C and slowly drained through a chromatography column containing 1 ml of oligo dT cellulose. The permeate was collected and drained again through the column. The column was then washed with 20 ml of a solution containing 0.15 M sodium chloride, 0.015 M sodium phosphate (pH 7.6) and 0.5% sodium dodecyl sulfate. The attached DNA was finally cleaved with 1 ml of 0.02 M NaOH. This solution was recovered and its radioactivity determined.

125 721 46 6125 721 46 6

Tulos: I-aktiivisuus (cpm) 05 Näyte: infektoidut solut Kontrollisolut 5230 325 10Result: I activity (cpm) 05 Sample: infected cells Control cells 5230 325 10

Esimerkki 2Example 2

Chlamydia trachomatiksen DNA:n tunnistaminen käyttäen 15 bioti ini-streptavidi inia 125Identification of Chlamydia trachomatis DNA using 15 bioti ini-streptavidin inia 125

Detektorikoettimena käytettiin I:lla leimattua rekom-binanttifaagia mkTH 1245, joka sisältää kaksi BamHI - Sali DNA fragmenttia kloonista pkTH 1220, jotka yhdessä ovat 20 kytkettynä Ml3mp8 vektoriin. Klooni pkTH 1220 on deponoitu kantakokoelmaan Deutsche Sammlung von Mikroorganismen numerolla DSM 2825 ja on kuvattu julkaisussa Palva et ai., FEMS Microbiology Letters 23, 83-89, 1984.I-labeled recombinant phage mkTH 1245 containing two BamHI-SalI DNA fragments from clone pkTH 1220, together linked to the M13mp8 vector, was used as a detector probe. Clone pkTH 1220 has been deposited in the strain collection Deutsche Sammlung von Microorganism under number DSM 2825 and is described in Palva et al., FEMS Microbiology Letters 23, 83-89, 1984.

25 Kiinnitinkoettimena käytettiin rekombinanttiplasmidia pkTHThe recombinant plasmid pkTH was used as a probe

1250. Tämä plasmidi koostuu 2,9 kb:n Sali - Clal fragmentista plasmidista pkTH 1220 (DSM 2825) sekä vektorista pAT 153. pkTH 1250 DNA:han liitettiin biotiinimolekyylejä kovalentti-sesti käyttäen tunnettua "nick-translaatio" -menetelmää 30 (Rigby et ai., J. Mol. Biol. 113, 237-251, 1977) ja biotine- ll-UTP:ta substraattina (Bethesda Research Laboratories, BRL). Kiinnitin-DNA keitettiin puskurissa 10 mM Tris-Cl pH 7,6, 1 mM EDTA 5 min ennen käyttöä.1250. This plasmid consists of a 2.9 kb SalI-ClaI fragment from plasmid pkTH 1220 (DSM 2825) and vector pAT 153. Biotin molecules were covalently ligated to pkTH 1250 DNA using a known "nick translation" method 30 (Rigby et al. et al., J. Mol. Biol. 113, 237-251, 1977) and biotin-11-UTP as a substrate (Bethesda Research Laboratories, BRL). Fastener DNA was boiled in 10 mM Tris-Cl pH 7.6, 1 mM EDTA for 5 min before use.

35 Näytteenä oli rekombinanttiplasmidi pkTH 1220 (DSM 2825).The sample was the recombinant plasmid pkTH 1220 (DSM 2825).

7 72146 Tämä plasmidi sisältää noin 10 kb Chlamydia trachomatikselle tunnusomaista DNA:ta kytkettynä vektoriin pBR322. Plasmidi toimii malli-DNA:na edustaen bakteerin genomi-DNA:ta. Ennen käyttöä plasmidia keitettiin 5 min 0,02 M NaOH:ssa, jonka 05 jälkeen liuosta neutraloitiin etikkahapolla.7 72146 This plasmid contains approximately 10 kb of Chlamydia trachomatis-specific DNA ligated into the vector pBR322. The plasmid acts as model DNA, representing the genomic DNA of the bacterium. Prior to use, the plasmid was boiled for 5 min in 0.02 M NaOH, after which the solution was neutralized with acetic acid.

Affiniteettimateriaalina käytetty Streptavidiini kytkettiin CNBr-aktivoituun Sepharoseert®^(Axen et ai., Nature 214, 1302-1304, 1967).Streptavidin used as an affinity material was coupled to CNBr-activated Sepharoseert® (Axen et al., Nature 214, 1302-1304, 1967).

1010

Testiä varten yhdistettiin koeputkessa 500.000 cpm koetinta, 50 ng kiinnitin DNA:ta ja 10 ng näyte DNA:ta. Tilavuus asetettiin 20 jul:ksi ja puskuriliuos oli sama kuin esimerkissä 1. Kontrolli-DNA oli vasikan kateenkorvan DNA.For the assay, 500,000 cpm of probe, 50 ng of fixative DNA, and 10 ng of sample DNA were combined in a test tube. The volume was set at 20 and the buffer solution was the same as in Example 1. The control DNA was calf thymus DNA.

1515

Seosta inkuboitiin 60 min 65°C:n lämpötilassa. Tämän jälkeen lisättiin 500 yul puskuriliuosta, jonka koostumus oli: 0,1 M Tris-Cl pH 7,5, 0,1 M NaCl, 2 mM MgClj, 0,05 % Triton x-100. Liuos fraktioitiin lopulta Streptavidiini-Sepharos^^-pylvääs-20 sä, siten että biotinyloitu DNA tarttui Streptavidiiniin, mutta muu DNA meni patsaan läpi. Radioaktiivinen koetin tarttui vain hybridimuodostuksen seurauksena. Tarttunut radioaktiivisuus määritettiin siirtämällä pylväs kokonaisuudessaan gammalaskijän laskentaputkeen.The mixture was incubated for 60 min at 65 ° C. Then, 500 μl of a buffer solution consisting of: 0.1 M Tris-Cl pH 7.5, 0.1 M NaCl, 2 mM MgCl 2, 0.05% Triton x-100 was added. The solution was finally fractionated on a Streptavidin-Sepharos column so that the biotinylated DNA adhered to the Streptavidin but other DNA passed through the column. The radioactive probe adhered only as a result of hybrid formation. Adherent radioactivity was determined by transferring the entire column to a gamma counter counting tube.

25 12525 125

Tulos: I-aktiivisuus (cpm) 30 Näyte: 10 ng pkTH 1220 10 ng kontrolli-DNA:ta 1350 115 8 721 46Result: I activity (cpm) 30 Sample: 10 ng pkTH 1220 10 ng control DNA 1350 115 8 721 46

Esimerkki 3Example 3

Plasmidin pBR322 DNA;n identifioiminen käyttäen antigeeni-vasta-aineparia, 05Identification of plasmid pBR322 DNA using antigen-antibody pair, 05

Detektorikoettimena käytettiin plasmidin pBR322 johdannaista, josta Pstl-Sall-fragmentti (3613-3651) on poistettu. Plasmidi leimattiin fotobiotiinilla käyttäen tunnettua menetelmää (Forster et ai., Nucleic Acids Res. 13, 745-761, 1985) ja 10 kaupallisia reagensseja.A derivative of plasmid pBR322 from which the PstI-SalI fragment (3613-3651) has been removed was used as a detector probe. The plasmid was labeled with photobiotin using a known method (Forster et al., Nucleic Acids Res. 13, 745-761, 1985) and 10 commercial reagents.

Kiinnitinkoettimena käytettiin rekombinanttifaagin M13mpll DNArta, johon plasmidin pBR322 Pstl-Sall-fragmentti oli liitetty. DNA oli sulfonoitu tunnettua menetelmää käyttäen 15 (Orgenics Ltd. Yavne, Israel).Recombinant phage M13mp111 DNA to which the PstI-SalI fragment of plasmid pBR322 was ligated was used as a probe probe. DNA was sulfonated using a known method (Orgenics Ltd. Yavne, Israel).

Näytteenä oli E. Coli HB101, johon oli liitetty plasmidi pBR322. Plasmidin pBR322 määrää lisättiin käyttäen kloramfenikoliamplifikaatiota (Maniatis et ai. Molecular 20 Cloning, A laboratory manual, Cold Spring Harbor Laboratory 1982). Bakteerisolut rikottiin lysotsyymillä ja niitä keitettiin NaOHsssa kuten julkaisussa Palva, J.Clin. Microbiol. 1J3, 92-100, 1983 on kuvattu.The sample was E. Coli HB101 to which plasmid pBR322 had been ligated. The amount of plasmid pBR322 was increased using chloramphenicol amplification (Maniatis et al. Molecular Cloning, A laboratory manual, Cold Spring Harbor Laboratory 1982). Bacterial cells were disrupted with lysozyme and boiled in NaOH as described in Palva, J. Clin. Microbiol. 1J3, 92-100, 1983.

25 Monoklonaaliset antisulfonivasta-aineet kiinnitettiin polystyreenistä valmistettujen mikrotiitterilevyjen kuoppiin standardimenetelmin (McKearn, Hybridomas: A New Dimension in Biological Analyses, ed. Kennett et ai., Plenum Press, 1980).Monoclonal antibodies were attached to the wells of polystyrene microtiter plates by standard methods (McKearn, Hybridomas: A New Dimension in Biological Analyzes, ed. Kennett et al., Plenum Press, 1980).

30 Testiä varten 5x10^ rikottua E. coli solua (sekä ilman että liitettynä pBR322-plasmidiin), 100 ng kiinnitin-DNA:ta ja 100 ng detektori-DNA:ta yhdistettiin hybridisaatioliuokseksi, jonka tilavuus säädettiin 50yul:ksi. Hybridisaatio-olosuhteet olivat samat kuin esimerkissä 1 lukuunottamatta sitä, että 9 72146 lisättiin 5 % polyetyleeniglykolia (PEG 6000) ja natriumdode-kyylisulfaattipitoisuus oli 0,1 %.For the assay, 5x10 6 disrupted E. coli cells (both airless and ligated into pBR322), 100 ng of fixer DNA, and 100 ng of detector DNA were pooled into a hybridization solution adjusted in volume to 50. The hybridization conditions were the same as in Example 1 except that 5% polyethylene glycol (PEG 6000) was added and the sodium dodecyl sulfate content was 0.1%.

Hybridisaation jälkeen liuos laimennettiin 250 yul:ksi lisää-05 mällä 0,02 M natriumfostaattia (pH 7,6), jonka jälkeen liuos siirrettiin mikrotiitterilevyn kuoppaan, johon vasta-aine oli kiinnitetty. Tämän jälkeen inkuboitiin 2 tuntia 37°C:ssa. Mikrotiitterilevyn kuoppaa pestiin sen jälkeen 0,15 M natriumkloridi-, 0,02 M natriumfosfaatti-, 0,05 % triton-10 X-100-liuoksella.After hybridization, the solution was diluted to 250 with the addition of 0.02 M sodium phosphate (pH 7.6), after which the solution was transferred to a well of a microtiter plate to which the antibody was attached. It was then incubated for 2 hours at 37 ° C. The well of the microtiter plate was then washed with 0.15 M sodium chloride, 0.02 M sodium phosphate, 0.05% Triton-10 X-100 solution.

Detektorikoetin havaittiin lisäämällä streptavidiinia (BRL), pesemällä, lisäämällä biotinyloitua alkaalista fosfataasia (BRL) ja pesemällä kuten julkaisussa Leary et ai., Proc.The detector probe was detected by the addition of streptavidin (BRL), washing, addition of biotinylated alkaline phosphatase (BRL) and washing as described in Leary et al., Proc.

15 Natl. Acad. Sei. USA, 80, 4045-4049, 1983 on kuvattu. Lopuksi lisättiin 250 μΐ paranitrofenyylifosfaattiliuosta (35 mg/ml, Sigma) dietanoliamiinipuskurissa (pH 10). 60 minuutin kuluttua reaktio pysähdytettiin ja absorbanssi mitattiin 410 nm:ssa.15 Natl. Acad. Sci. USA, 80, 4045-4049, 1983. Finally, 250 μl of paranitrophenyl phosphate solution (35 mg / ml, Sigma) in diethanolamine buffer (pH 10) was added. After 60 minutes, the reaction was stopped and the absorbance was measured at 410 nm.

2020

Tulos: A 410 nm 25 Näyte: solut joihin oli Kontrollisolut liitetty pBR322 (ilman pBR322) > 2 0,1Result: Δ 410 nm 25 Sample: cells to which Control cells were attached pBR322 (without pBR322)> 2 0.1

Claims (7)

1. Menetelmä nukleiinihappojen tunnistamiseksi hybridisaa-tiomenetelmällä käyttäen kahta, samassa liuosfaasissa olevaa 05 koetinta, joista n.k. detektorikoetin on leimattu sopivalla, mitattavalla merkkiaineella tunnettu siitä, että n.k. kiinnitinkoettimeen on liitetty komponentti, joka voi toimia osapuolena affiniteettiparissa, jolloin hybridisaatio-reaktiossa muodostunut kiinnitinkoetin:näyte:detektorikoe-10 tin-hybridi voidaan eristää muista hybridisaatioseoksessa olevista komponenteista kiinteään kantajaan kiinnitetyn affiniteettiparin toisen osapuolen avulla.A method for identifying nucleic acids by a hybridization method using two 05 probes in the same solution phase, of which e.g. the detector probe is labeled with a suitable, measurable tracer characterized in that the so-called the fastener is attached to the probe component of the affinity pair can act as a party, wherein the hybridization reaction, the resulting fastener probe: Sample: 10 detektorikoe-tin-hydride can be isolated from other components of the hybridization mixture for the second party attached to the solid support by means of an affinity pair. 2. Patenttivaatimuksen 1 mukainen menetelmä, tunnettu 15 siitä, että affiniteettipari on biotiini-avidiini tai biotiini-streptavidiini.Process according to Claim 1, characterized in that the affinity pair is biotin-avidin or biotin-streptavidin. 3. Patenttivaatimuksen 1 mukainen menetelmä, tunnettu siitä, että affiniteettipari on homopolynukleotidipari. 20The method of claim 1, characterized in that the affinity pair is a homopolynucleotide pair. 20 4. Patenttivaatimusten 1 ja 3 mukainen menetelmä, tunnettu siitä, että affiniteettipari on poly dC -poly dG.Method according to Claims 1 and 3, characterized in that the affinity pair is poly dC -poly dG. 5. Patenttivaatimusten 1 ja 3 mukainen menetelmä, tunnettu siitä, että affiniteettipari on poly dA -poly dT.Method according to Claims 1 and 3, characterized in that the affinity pair is poly dA -poly dT. 6. Patenttivaatimusten 1 ja 3 mukainen menetelmä, 30 tunnettu siitä, että affiniteettipari on poly dA -poly U.Method according to Claims 1 and 3, characterized in that the affinity pair is poly dA -poly U. 7. Patenttivaatimuksen 1 mukainen menetelmä tunnettu siitä, että affiniteettipari on antigeeni-vasta-aine.The method of claim 1, wherein the affinity pair is an antigen-antibody.
FI850004A 1985-01-02 1985-01-02 Procedure for Identifying Nucleic Acids. FI72146C (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
FI850004A FI72146C (en) 1985-01-02 1985-01-02 Procedure for Identifying Nucleic Acids.
CH5378/85A CH666696A5 (en) 1985-01-02 1985-12-17 METHOD FOR IDENTIFYING NUCLEIC ACIDS.
GB08531414A GB2169403B (en) 1985-01-02 1985-12-20 Identification of nucleic acids
BE0/216059A BE903937A (en) 1985-01-02 1985-12-24 METHOD FOR THE IDENTIFICATION OF NUCLEIC ACIDS.
JP60299797A JPH0669400B2 (en) 1985-01-02 1985-12-27 Nucleic acid identification method
NO855308A NO166743C (en) 1985-01-02 1985-12-27 PROCEDURE FOR IDENTIFICATION OF NUCLEIC ACIDS.
HU855030A HU196453B (en) 1985-01-02 1985-12-29 Process for the identification of nucleinic acids
RO121637A RO94651B (en) 1985-01-02 1985-12-30 Method for identifying the nucleic acids
LU86238A LU86238A1 (en) 1985-01-02 1985-12-30 METHOD FOR THE IDENTIFICATION OF NUCLEIC ACIDS
IT23408/85A IT1201514B (en) 1985-01-02 1985-12-30 PROCEDURE FOR THE IDENTIFICATION OF NUCLEIC ACIDS
DE19853546312 DE3546312A1 (en) 1985-01-02 1985-12-30 METHOD FOR IDENTIFYING NUCLEIC ACIDS
AT0376785A AT397514B (en) 1985-01-02 1985-12-30 METHOD FOR IDENTIFYING NUCLEIC ACIDS
ZA859895A ZA859895B (en) 1985-01-02 1985-12-30 A method for the identification of nucleic acids
FR858519394A FR2575493B1 (en) 1985-01-02 1985-12-30 METHOD FOR THE IDENTIFICATION OF NUCLEIC ACIDS
CA000498834A CA1271705A (en) 1985-01-02 1985-12-31 Method for the identification of nucleic acids
IE333385A IE58290B1 (en) 1985-01-02 1985-12-31 A method for the identification of nucleic acids
AU51748/85A AU561382B2 (en) 1985-01-02 1985-12-31 Identification of nucleic acid by hybridization probes
NLAANVRAGE8503597,A NL189427C (en) 1985-01-02 1985-12-31 METHOD FOR IDENTIFYING NUCLEIC ACIDS.
IL77489A IL77489A (en) 1985-01-02 1985-12-31 Method for the identification of nucleic acids in solution by hybridisation with at least two probes one labelled,the other bonded to one component of a specific binding pair
SE8600011A SE463212B (en) 1985-01-02 1986-01-02 METHOD FOR IDENTIFYING NUCLEIC ACIDS
DK000386A DK164932C (en) 1985-01-02 1986-01-02 PROCEDURE FOR IDENTIFICATION OF NUCLEIC ACIDS BY A METHOD OF HYBRIDIZATION, WHICH AT LEAST TWO SUNS ARE IN THE SAME SOLUTION PHASE, SINCE THE ONE, THE DETECTOR SENSOR, IS MARKED WITH A DETECTABLE MARKET

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI850004 1985-01-02
FI850004A FI72146C (en) 1985-01-02 1985-01-02 Procedure for Identifying Nucleic Acids.

Publications (4)

Publication Number Publication Date
FI850004A0 FI850004A0 (en) 1985-01-02
FI850004L FI850004L (en) 1986-07-03
FI72146B FI72146B (en) 1986-12-31
FI72146C true FI72146C (en) 1987-04-13

Family

ID=8520136

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850004A FI72146C (en) 1985-01-02 1985-01-02 Procedure for Identifying Nucleic Acids.

Country Status (21)

Country Link
JP (1) JPH0669400B2 (en)
AT (1) AT397514B (en)
AU (1) AU561382B2 (en)
BE (1) BE903937A (en)
CA (1) CA1271705A (en)
CH (1) CH666696A5 (en)
DE (1) DE3546312A1 (en)
DK (1) DK164932C (en)
FI (1) FI72146C (en)
FR (1) FR2575493B1 (en)
GB (1) GB2169403B (en)
HU (1) HU196453B (en)
IE (1) IE58290B1 (en)
IL (1) IL77489A (en)
IT (1) IT1201514B (en)
LU (1) LU86238A1 (en)
NL (1) NL189427C (en)
NO (1) NO166743C (en)
RO (1) RO94651B (en)
SE (1) SE463212B (en)
ZA (1) ZA859895B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288609A (en) * 1984-04-27 1994-02-22 Enzo Diagnostics, Inc. Capture sandwich hybridization method and composition
US6060237A (en) * 1985-02-26 2000-05-09 Biostar, Inc. Devices and methods for optical detection of nucleic acid hybridization
IL79112A (en) * 1985-06-13 1992-01-15 Abbott Lab Method for the isolation of a nucleic acid sequence and kit for performing a hybridization assay
US4868105A (en) * 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US4910300A (en) * 1985-12-11 1990-03-20 Chiron Corporation Method for making nucleic acid probes
US4882269A (en) * 1985-12-13 1989-11-21 Princeton University Amplified hybridization assay
FI76119C (en) * 1986-02-27 1988-09-09 Orion Yhtymae Oy QUANTITATIVE BEARING OF NUCLEIN SYRAMOLEKYLER AND REAGENTS FOERPACKNING SOM ANVAENDS VID FOERFARANDET.
AU622104B2 (en) * 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
FI894132L (en) * 1987-06-26 1989-09-01 Du Pont AFFINITETSAVLAEGSNING AV KONTAMINERANDE SEKVENSER UR KLONAD HYBRIDNUCLEIINSYRA GENOM ATT ANVAENDA INFAONGANDE PAERLOR.
AU623090B2 (en) * 1987-07-31 1992-05-07 Gen-Probe Incorporated Assay for polynucleotides employing oligonucleotides to eliminate undesirable cross reactions
EP0305145A3 (en) * 1987-08-24 1990-05-02 Ortho Diagnostic Systems Inc. Methods and probes for detecting nucleic acids
EP0304845A3 (en) * 1987-08-28 1991-03-06 Profile Diagnostic Sciences Inc. Method and kit for assaying gene expressions
CA1325761C (en) * 1987-12-25 1994-01-04 Takanori Oka Method of detecting an intended nucleic acid in a sample
DE3800644A1 (en) * 1988-01-12 1989-07-20 Boehringer Mannheim Gmbh PROCESS FOR HIGHLY SPECIFIC DETECTION OF NUCLEIC ACIDS IN SOLUTION
US5104791A (en) * 1988-02-09 1992-04-14 E. I. Du Pont De Nemours And Company Particle counting nucleic acid hybridization assays
DE68919706T2 (en) * 1988-05-10 1995-04-13 Du Pont METHOD FOR QUICK DETECTING NUCLEIC ACIDS.
US5185243A (en) * 1988-08-25 1993-02-09 Syntex (U.S.A.) Inc. Method for detection of specific nucleic acid sequences
AU629845B2 (en) * 1988-08-30 1992-10-15 Abbott Laboratories Detection and amplification of target nucleic acid sequences
US5858652A (en) * 1988-08-30 1999-01-12 Abbott Laboratories Detection and amplification of target nucleic acid sequences
GB2225112A (en) * 1988-11-22 1990-05-23 Ici Plc Hybridisation probes
US5082935A (en) * 1988-12-15 1992-01-21 Amoco Corporation Diagnostic reagents made by attaching cytidine containing nucleic acid probes to amino functionalized solid supports by bisulfite mediated transamination
AU5188190A (en) * 1989-02-06 1990-08-24 Gene-Trak Systems Probes and methods for the detection of listeria
CA2049043A1 (en) 1989-03-10 1990-09-11 Mark L. Collins Immobilized oligo-nucleotide probes and uses therefor
AU5347690A (en) * 1989-03-10 1990-10-09 Gene-Trak Systems Preventing interference with affinity capture schemes
US5334501A (en) * 1989-07-11 1994-08-02 Microprobe Corporation Quantification of bacteria using a nucleic acid hybridization assay
JPH05501052A (en) * 1989-07-11 1993-03-04 マイクロプローブ・コーポレーション Quantification of bacteria using a nucleic acid hybridization assay
GB8924989D0 (en) * 1989-11-06 1989-12-28 Scotgen Ltd Method and device for the detection of antibiotic resistance
US5580970A (en) * 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
AU7429591A (en) * 1990-04-18 1991-10-24 Gene-Trak Systems Nucleic acid probes for the detection of giardia lamblia
EP0529070A1 (en) * 1991-02-27 1993-03-03 Amoco Corporation Methods for improving the sensitivity of hybridization assays
WO1993020234A1 (en) * 1992-03-31 1993-10-14 E.I. Du Pont De Nemours And Company A rapid, high capacity nucleic acid based assay
US7713528B1 (en) 1993-02-18 2010-05-11 Enzo Therapeutics, Inc. Method for in vivo delivery of active compounds using reagent conjugate
RU2146707C1 (en) * 1996-04-11 2000-03-20 Куликова Валентина Филипповна Method of detection of analyzed sequence of nucleic acid
US5853993A (en) * 1996-10-21 1998-12-29 Hewlett-Packard Company Signal enhancement method and kit
GB0016833D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (2)
US7465540B2 (en) 2000-09-21 2008-12-16 Luminex Corporation Multiple reporter read-out for bioassays
CN1303221C (en) * 2003-01-27 2007-03-07 英科新创(厦门)科技有限公司 Method for detecting target nucleic acid using affinity amplifying integrated signal group

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI63596C (en) * 1981-10-16 1983-07-11 Orion Yhtymae Oy MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER
FR2518755B1 (en) * 1981-12-23 1986-04-11 Pasteur Institut PROBE CONTAINING MODIFIED NUCLEIC ACID RECOGNIZABLE BY SPECIFIC ANTIBODIES AND USE OF THE SAME TO DETECT AND CHARACTERIZE A HOMOLOGATED DNA SEQUENCE
GB8306426D0 (en) * 1983-03-09 1983-04-13 Malcolm A D B Detecting polynucleotide sequence
CA1228811A (en) * 1983-05-05 1987-11-03 Robert G. Pergolizzi Assay method utilizing polynucleotide sequences
NO843838L (en) * 1983-09-26 1985-03-27 Ortho Diagnostic Systems Inc PROCEDURE FOR DETECTING NUCLEIC ACID
ZA849594B (en) * 1983-12-12 1985-08-28 Miles Lab Nucleic acid hybridization assay employing antibodies to intercalation complexes
FR2558172B1 (en) * 1984-01-16 1986-06-13 Inst Nat Sante Rech Med PROBE CONTAINING MODIFIED NUCLEIC ACID AND RECOGNITION BY SPECIFIC ANTIBODIES AND USE OF SUCH PROBE AND THESE SPECIFIC ANTIBODIES TO DETECT AND CHARACTERIZE A HOMOLOGATED DNA SEQUENCE
CA1223222A (en) * 1984-02-22 1987-06-23 Nanibhushan Dattagupta Immobilized nucleic acid-containing probes
FR2560298B1 (en) * 1984-02-28 1988-07-15 Mors METHOD AND DEVICE FOR ADJUSTING THE PRECISION OF THE PRESSURE DROP OF A FLUID INITIALLY AT HIGH PRESSURE, SUCH AS A HYDRAULIC FLUID FOR EXAMPLE SUPPLYING A HYDRAULIC GROUP, AND APPLICATION OF THE METHOD TO THE DEVICE IN A HYDRAULIC GROUP OR PLANT INTEGRATED OR NOT, ESPECIALLY IN A MACHINE TABLE OR ANY TOOL SUPPORT DEVICE
NZ211453A (en) * 1984-03-22 1989-01-06 Biotechnology Research Enterpr Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides
US4766062A (en) * 1984-05-07 1988-08-23 Allied Corporation Displacement polynucleotide assay method and polynucleotide complex reagent therefor

Also Published As

Publication number Publication date
IE58290B1 (en) 1993-08-25
CH666696A5 (en) 1988-08-15
DK164932C (en) 1993-01-25
BE903937A (en) 1986-04-16
HU196453B (en) 1988-11-28
NL189427C (en) 1993-04-01
FI850004A0 (en) 1985-01-02
DE3546312A1 (en) 1986-07-10
NO166743C (en) 1991-08-28
JPH0669400B2 (en) 1994-09-07
SE8600011L (en) 1986-07-03
SE8600011D0 (en) 1986-01-02
NL189427B (en) 1992-11-02
CA1271705A (en) 1990-07-17
FR2575493A1 (en) 1986-07-04
HUT40166A (en) 1986-11-28
IT1201514B (en) 1989-02-02
ZA859895B (en) 1986-08-27
RO94651B (en) 1988-07-01
NO855308L (en) 1986-07-03
DK164932B (en) 1992-09-07
GB2169403B (en) 1988-06-08
ATA376785A (en) 1993-09-15
AT397514B (en) 1994-04-25
NL8503597A (en) 1986-08-01
NO166743B (en) 1991-05-21
FI72146B (en) 1986-12-31
DK386A (en) 1986-07-03
GB8531414D0 (en) 1986-02-05
LU86238A1 (en) 1986-04-14
DK386D0 (en) 1986-01-02
DE3546312C2 (en) 1992-08-06
RO94651A (en) 1988-06-30
SE463212B (en) 1990-10-22
IL77489A (en) 1991-01-31
IE853333L (en) 1986-07-02
FI850004L (en) 1986-07-03
GB2169403A (en) 1986-07-09
JPS61185200A (en) 1986-08-18
IT8523408A0 (en) 1985-12-30
AU561382B2 (en) 1987-05-07
FR2575493B1 (en) 1990-01-26
AU5174885A (en) 1986-07-17

Similar Documents

Publication Publication Date Title
FI72146C (en) Procedure for Identifying Nucleic Acids.
US4563417A (en) Nucleic acid hybridization assay employing antibodies to intercalation complexes
US4562159A (en) Diagnostic test for hepatitis B virus
AU597896B2 (en) Method and kit for performing nucleic acid hybridization assays
CA1253777A (en) Nucleic acid hybridization assay employing immobilized rna probes
US6555317B2 (en) Detection of differences in nucleic acids
US5981171A (en) Diagnostic assays using nucleic acid probes
JPH0740960B2 (en) Nucleic acid detection kit
EP0146815B1 (en) Nucleic acid hybridization assay employing antibodies to intercalation complexes
US4840892A (en) Polynucleotide hybridization probes
Stark et al. Immunomagnetic separation and solid-phase detection of Bordetella pertussis
EP0172153B1 (en) Polynucleotide hybridization probes
EP0253894A1 (en) Dna probe and method of preparing the same
WO2000043545A2 (en) Detection of drug resistant organisms
JPH0531108B2 (en)
EP0401313B1 (en) Macromolecular conjugate
WO2000043546A9 (en) Detection of drug resistant organisms

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SANGTEC MEDICAL AB

FG Patent granted

Owner name: SANGTEC MOLECULAR DIAGNOSTICS AB

MA Patent expired